| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent |
| 09/11/2003 | US20030170792 MAGE-3 peptides presented by HLA class ll molecules |
| 09/11/2003 | US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 09/11/2003 | US20030170334 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 09/11/2003 | US20030170327 Vitamin and zinc monomethionine compositions |
| 09/11/2003 | US20030170276 Modified msbB gene |
| 09/11/2003 | US20030170275 Such as pain, mental disorders such as schizophrenia and stress-related disorders such as depression using, especially, M. vaccae material. |
| 09/11/2003 | US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 09/11/2003 | US20030170268 Administering a fusion protein of a heat shock protein or immunostimulatory fragment and a human papilloma virus protein or an antigenic fragment; or a nucleic acid coding the fusion protein |
| 09/11/2003 | US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/11/2003 | US20030170218 Fungicide and method for producing the same |
| 09/11/2003 | US20030170217 Bifidobacterium in the treatment of inflammatory disease |
| 09/11/2003 | US20030170216 SYN3 compositions and methods |
| 09/11/2003 | US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
| 09/11/2003 | US20030170214 Method for producing a bio-artificial transplant |
| 09/11/2003 | US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 09/11/2003 | US20030170211 For delivering alphavirus replicon DNA into an animal or animal cells with the replicon encoding one or more heterologous genes to be expressed in the animal or the animal cells |
| 09/11/2003 | US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing |
| 09/11/2003 | US20030170184 Administering to a mammal in need of such treatment a lactic bacteria strain that is exogenous to oral microflora, which strain is selected for its ability to adhere to teeth pellicle and to produce a growth inhibition factor |
| 09/10/2003 | EP1342765A2 Hot melt pressure sensitive adhesives for disposable articles |
| 09/10/2003 | EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours |
| 09/10/2003 | EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 09/10/2003 | EP1341565A2 Drug delivery compositions and coated medical devices |
| 09/10/2003 | EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions |
| 09/10/2003 | EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects |
| 09/10/2003 | EP1341545A1 Bone putty and method |
| 09/10/2003 | EP1341517A1 A skin cream composition |
| 09/10/2003 | EP1341496A2 COMPOSITIONS AND METHODS FOR REDUCING THE AMOUNT OF i SALMONELLA /i IN LIVESTOCK |
| 09/10/2003 | EP1341467A2 Method for precipitating red blood cells |
| 09/10/2003 | EP1131080B1 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 09/10/2003 | EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 09/10/2003 | EP1093375A4 A fibrin sealant from clotting factors in fish blood |
| 09/10/2003 | EP1085816B1 Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 09/10/2003 | EP1032407B1 Use of putamen ovi |
| 09/10/2003 | EP1007632A4 Isolation of bone and cartilage precursor cells |
| 09/10/2003 | CN1441842A Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/10/2003 | CN1441676A Method of treatment using ligand-immunogen conjugates |
| 09/10/2003 | CN1441049A Chinese herbal medicine tonic wine and its making process |
| 09/10/2003 | CN1440796A Medicine for clearing away heat and toxic matter, promoting diuresis and stopping itching |
| 09/10/2003 | CN1440773A Prepn process of Qingkailing injection and injection powder and its quality control method |
| 09/10/2003 | CN1440758A Bioactive hill wasp powder and its prepn |
| 09/10/2003 | CN1440757A Bioactive Chinese woodfrog oil lecithin powder and its prepn |
| 09/10/2003 | CN1440756A Medicine for treating high fever and diseases caused by high fever and its prepn process |
| 09/10/2003 | CN1440755A Laryngopharyngitis treating medicine |
| 09/10/2003 | CN1440692A Biological ant tea as eyesight health beverage and its production process |
| 09/10/2003 | CN1120721C External applied ointment for treating piles |
| 09/10/2003 | CN1120720C Chinese medicine capsule for curing prolapse of lumber intervertebral disc and preparing method thereof |
| 09/10/2003 | CN1120717C Plaster |
| 09/10/2003 | CN1120716C Plaster for curing bony spur and its preparing process |
| 09/10/2003 | CN1120714C Chinese medicine preparation for curing necrosis of femoral head and its preparing method |
| 09/10/2003 | CN1120713C Application of Chinese medicinal composition in preparing medicines |
| 09/10/2003 | CN1120709C Embryo factor of fowls and its extracting method and medicinal use |
| 09/09/2003 | US6617450 P-glycoproteins and uses thereof |
| 09/09/2003 | US6617356 Comprising a stable suspension of silicon dioxide in a number selected from the group consisting of food grade vegetable oils and mineral oils, and the carrier being in the form of pourable gel |
| 09/09/2003 | US6617161 Serum-free cell growth medium |
| 09/09/2003 | US6617159 Serum free medium for chondrocyte cells |
| 09/09/2003 | US6617158 Contacting progenitor cells ex vivo with a cytokine (transforming growth factor); use for treating anemia and other blood disorders |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 09/09/2003 | US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6617101 Lipophilic quenching of viral inactivating agents |
| 09/09/2003 | US6617100 Solid phase quenching systems |
| 09/09/2003 | US6616927 Processes for production of immunoglobulin A in milk |
| 09/09/2003 | US6616925 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 09/09/2003 | CA2239498C Bioartificial devices and cellular matrices therefor |
| 09/09/2003 | CA2139937C Antioxidation food product, antioxidation preparation and antioxidation method |
| 09/04/2003 | WO2003073097A2 Methods for isolating ligands e.g. t cell epitopes |
| 09/04/2003 | WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 09/04/2003 | WO2003072748A2 Bioengineered tissue substitutes |
| 09/04/2003 | WO2003072728A2 Cellular trans-differentiation |
| 09/04/2003 | WO2003072707A2 Compositions comprising reproductive cell media and methods for using such compositions |
| 09/04/2003 | WO2003072609A1 Tick chitinase |
| 09/04/2003 | WO2003072133A2 Immunostimulatory agent comprising a biomass of methanotrophic bacterium |
| 09/04/2003 | WO2003072119A1 External compositions for the skin |
| 09/04/2003 | WO2003072118A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics |
| 09/04/2003 | WO2003072117A1 Dialyzed leukocyte extract for the treatment of infectious diseases in animals |
| 09/04/2003 | WO2003072115A1 Ceramic composite materials |
| 09/04/2003 | WO2003072029A2 Methods of extending corneal graft survival |
| 09/04/2003 | WO2003072016A2 Pharmaceutical compositions in particulate form |
| 09/04/2003 | WO2003071883A1 Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations |
| 09/04/2003 | WO2003063902A3 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers |
| 09/04/2003 | WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 09/04/2003 | WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 09/04/2003 | WO2003020958A3 Campylobacter typing |
| 09/04/2003 | WO2003018743A3 Emu-based formulations for wound treatment |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 09/04/2003 | WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 09/04/2003 | WO2002045723A3 Inflammatory cytokine secretion inhibition with modified mammalian blood |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002013760A9 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 09/04/2003 | WO2001092299A3 Adenovirus particles with mutagenized fiber proteins |
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents |
| 09/04/2003 | US20030166614 Daily administering a mixture of anticholesterol agents comprising fish oil concentrate, niacin, and lecithin |
| 09/04/2003 | US20030166603 Using a p53- expressing viral vector as anticarcinogenic agents |